Theravectys Competitors and Similar CompaniesClear all

Theravectys's competitors and similar companies include Valneva, Neptunus and Glenmark Pharmaceuticals.

	Theravectys Theravectys is a vaccine company.	Valneva Valneva is a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases.	Neptunus Neptunus is a biotechnology company that produces and distributes medicines.	Glenmark Pharmaceuticals Glenmark Pharmaceuticals is a pharmaceutical company that develops and markets branded and generic formulations.
Founding Date	Founding Date 2005	Founding Date 2013	Founding Date 1989	Founding Date 1977
Type	Type Private	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech pharma	Tags Healthcare biotech pharma
Locations	Locations Paris, FR HQ Paris, FR	Locations Saint-Herblain, FR HQ Wien, AT Kirkland, CA Lyon, FR Solna, SE Fleet, GB Livingston, GB see more	Locations Shen Zhen Shi, CN HQ	Locations Mumbai, IN HQ Mumbai, IN
Employees	Employees 196% increase	Employees 713	Employees 1,485	Employees 14,989
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) €157.9m (FY, 2025)	Revenue (est.) ¥972m (FY, 2025)	Revenue (est.) ₹167.1b (FY, 2026)
Cost of goods	Cost of goods N/A	Cost of goods €8.2m (FY, 2025)	Cost of goods ¥653.9m (FY, 2025)	Cost of goods ₹47.5b (FY, 2026)
Gross profit	Gross profit N/A	Gross profit €177.7m (FY, 2025)	Gross profit ¥330.8m (FY, 2025)	Gross profit ₹127b (FY, 2026)
Net income	Net income N/A	Net income (€115.2m) (FY, 2025)	Net income (¥53.1m) (FY, 2025)	Net income ₹13.6b (FY, 2026)
Funding
Total funding raised	Total funding raised $ 31.7m	Total funding raised $ 51.7m	Total funding raised N/A	Total funding raised N/A